asurgeryАмбулаторная хирургияAmbulatornaya khirurgiya = Ambulatory Surgery (Russia)2712-87412782-2591ООО «ГРУППА РЕМЕДИУМ»10.21518/akh2022-001asurgery-326Research ArticleПИСЬМО В РЕДАКЦИЮLETTER TO THE EDITORCOVID-19-ассоциированная флебопатия – миф или реальность?COVID-19-associated phlebopathy – myth or reality?https://orcid.org/0000-0002-5358-7218ЛобастовК. В.LobastovK. V.

Лобастов Кирилл Викторович, к.м.н., доцент кафедры общей хирургии лечебного факультета,

117997, Москва, ул. Островитянова, д. 1

Kirill V. Lobastov, Cand. Sci. (Med.), Associate Professor of the Department of General Surgery of the Faculty of Medicine,

1, Ostrovityanov St., Moscow, 117997

lobastov_kv@mail.ruРоссийский национальный исследовательский медицинский университет имени Н.И. ПироговаРоссияPirogov Russian National Research Medical UniversityRussian Federation202316122022201198200Copyright © Лобастов К.В., 20232023Лобастов К.В.Lobastov K.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.a-surgeon.ru/jour/article/view/326

.

.

ReferencesБогачев В.Ю., Болдин Б.В., Туркин П.Ю., Дженина О.В. COVID-19-ассоциированная флебопатия как актуальная проблема современной флебологии. Амбулаторная хирургия. 2022;19(2):13–20. https://doi.org/10.21518/1995-1477-2022-19-2.Bogachev V.Yu., Boldin B.V., Turkin P.Yu., Dzhenina O.V. COVID-19-associated phlebopathy as a current problem of modern phlebology. Ambulatornaya Khirurgiya. 2022;19(2):13–20. (In Russ.) https://doi.org/10.21518/1995-1477-2022-19-2.Лобастов К.В., Счастливцев И.В., Порембская О.Я., Дженина О.В., Барганджия А.Б., Цаплин С.Н. COVID-19-ассоциированная коагулопатия: обзор современных рекомендаций по диагностике, лечению и профилактике. Амбулаторная хирургия. 2020;(3-4):36–51. https://doi.org/10.21518/1995-1477-2020-3-4-36-51.Lobastov K.V., Schastlivtsev I.V., Porembskaya O.Y., Dzenina O.V., Bargandzhiya A.B., Tsaplin S.N. COVID-19-associated coagulopathy: review of current recommendations for diagnosis, treatment and prevention. Ambulatornaya Khirurgiya. 2020;(3-4):36–51. (In Russ.) https://doi.org/10.21518/1995-1477-2020-3-4-36-51.Лобастов К.В., Порембская О.Я., Счастливцев И.В. Эффективность и безопасность применения антитромботической терапии при COVID-19. Амбулаторная хирургия. 2021;18(2):17–30. https://doi.org/10.21518/1995-1477-2021-18-2.Lobastov K.V., Porembskay O.Y., Schastlivtsev I.V. The effectiveness and safety of the use of antithrombotic therapy in COVID-19. Ambulatornaya Khirurgiya. 2021;18(2):17–30. (In Russ.) https://doi.org/10.21518/1995-1477-2021-18-2.Stepanov E., Lobastov K., Tsaplin S., Schastlivtsev I., Bargandzhiya A., Laberko L., Rodoman G. Efficacy and safety of increased doses of anticoagulants in COVID-19 patients: A systematic review and meta-analysis. Vasc Invest Ther. 2022;5(3):59–67. Available at: https://www.vitonline.org/text.asp?2022/5/3/59/360870.Stepanov E., Lobastov K., Tsaplin S., Schastlivtsev I., Bargandzhiya A., Laberko L., Rodoman G. Efficacy and safety of increased doses of anticoagulants in COVID-19 patients: A systematic review and meta-analysis. Vasc Invest Ther. 2022;5(3):59–67. Available at: https://www.vitonline.org/text.asp?2022/5/3/59/360870.Han Q., Zheng B., Daines L., Sheikh A. Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms. Pathogens. 2022;11(2):269. https://doi.org/10.3390/pathogens11020269.Han Q., Zheng B., Daines L., Sheikh A. Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms. Pathogens. 2022;11(2):269. https://doi.org/10.3390/pathogens11020269.Золотухин И.А., Кириенко А.И. Функциональная венозная недостаточность (флебопатия) нижних конечностей: клиника, диагностика, лечение. Флебология. 2009;3(3):3–9. Режим доступа: https://elibrary.ru/item.asp?id=15235416.Zolotukhin I.A., Kirienko A.I. Functional venous insufficiency (phlebopathy) of the lower extremities: clinic, diagnosis, treatment. Flebologiya. 2009;3(3):3–9. (In Russ.) Available at: https://elibrary.ru/item.asp?id=15235416.Peiris S., Mesa H., Aysola A., Manivel J., Toledo J., Borges-Sa M. et al. Pathological findings in organs and tissues of patients with COVID-19: A systematic review. PLoS ONE. 2021;16(4):e0250708. https://doi.org/10.1371/journal.pone.0250708.Peiris S., Mesa H., Aysola A., Manivel J., Toledo J., Borges-Sa M. et al. Pathological findings in organs and tissues of patients with COVID-19: A systematic review. PLoS ONE. 2021;16(4):e0250708. https://doi.org/10.1371/journal.pone.0250708.Perrin M., Eklof B., van Rij A., Labropoulos N., Vasquez M., Nicolaides A. et al. Venous symptoms: the SYM Vein Consensus statement developed under the auspices of the European Venous Forum. Int Angiol. 2016;35(4):374–398. Available at: https://pubmed.ncbi.nlm.nih.gov/27081866/.Perrin M., Eklof B., van Rij A., Labropoulos N., Vasquez M., Nicolaides A. et al. Venous symptoms: the SYM Vein Consensus statement developed under the auspices of the European Venous Forum. Int Angiol. 2016;35(4):374–398. Available at: https://pubmed.ncbi.nlm.nih.gov/27081866/.Lattimer C.R., Kalodiki E., Geroulakos G., Hoppensteadt D., Fareed J. Are Inflammatory Biomarkers Increased in Varicose Vein Blood? Clin Appl Thromb Hemost. 2016;22(7):656–664. https://doi.org/10.1177/1076029616645330.Lattimer C.R., Kalodiki E., Geroulakos G., Hoppensteadt D., Fareed J. Are Inflammatory Biomarkers Increased in Varicose Vein Blood? Clin Appl Thromb Hemost. 2016;22(7):656–664. https://doi.org/10.1177/1076029616645330.Turner B.R.H., Machin M., Jasionowska S., Salim S., Onida S., Shalhoub J., Davies A.H. Systematic Review and meta-analysis of the Additional Benefit of Pharmacological Thromboprophylaxis for Endovenous Varicose Vein Interventions. Ann Surg. 2022. https://doi.org/10.1097/SLA.0000000000005709.Turner B.R.H., Machin M., Jasionowska S., Salim S., Onida S., Shalhoub J., Davies A.H. Systematic Review and meta-analysis of the Additional Benefit of Pharmacological Thromboprophylaxis for Endovenous Varicose Vein Interventions. Ann Surg. 2022. https://doi.org/10.1097/SLA.0000000000005709.Lattimer C.R., Fareed J., Hoppensteadt D., Maia P., Ligi D., Mannello F., Kalodiki E. Validation of a Gravitational Model to Study Local Endogenous Biomarkers in Chronic Venous Insufficiency. Eur J Vasc Endovasc Surg. 2018;56(6):865–873. https://doi.org/10.1016/j.ejvs.2018.08.004.Lattimer C.R., Fareed J., Hoppensteadt D., Maia P., Ligi D., Mannello F., Kalodiki E. Validation of a Gravitational Model to Study Local Endogenous Biomarkers in Chronic Venous Insufficiency. Eur J Vasc Endovasc Surg. 2018;56(6):865–873. https://doi.org/10.1016/j.ejvs.2018.08.004.Kakkos S.K., Nicolaides A.N. Efficacy of micronized purified flavonoid fraction (Daflon®) on improving individual symptoms, signs and quality oflife in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebocontrolled trials. Int Angiol. 2018;37(2):143–154. https://doi.org/10.23736/S0392-9590.18.03975-5.Kakkos S.K., Nicolaides A.N. Efficacy of micronized purified flavonoid fraction (Daflon®) on improving individual symptoms, signs and quality oflife in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebocontrolled trials. Int Angiol. 2018;37(2):143–154. https://doi.org/10.23736/S0392-9590.18.03975-5.

The authors declare that there are no conflicts of interest present.